search icon
cert-img

Certara Inc, Common Stock

CERT

NSQ

$11.4

+$0.08

(0.71%)

1D
Industry: Health Care Technology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.86B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
914.40K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.57
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$8.63 L
$17.75 H
$11.4

About Certara Inc, Common Stock

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara I more

Industry: Health Care TechnologySector: Health Care

Returns

Time FrameCERTSectorS&P500
1-Week Return-0.7%0.71%0.79%
1-Month Return-17.93%-5.6%6.04%
3-Month Return-4.84%-11.72%-1.11%
6-Month Return1.69%-10.81%-2.39%
1-Year Return-30.87%-7.12%11.69%
3-Year Return-43.9%-0.57%42.29%
5-Year Return-70.06%27.64%93.12%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue243.53M286.10M335.64M354.34M385.15M[{"date":"2020-12-31","value":63.23,"profit":true},{"date":"2021-12-31","value":74.28,"profit":true},{"date":"2022-12-31","value":87.15,"profit":true},{"date":"2023-12-31","value":92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue100.77M111.62M132.58M141.02M154.52M[{"date":"2020-12-31","value":65.21,"profit":true},{"date":"2021-12-31","value":72.24,"profit":true},{"date":"2022-12-31","value":85.8,"profit":true},{"date":"2023-12-31","value":91.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit142.76M174.49M203.07M213.31M230.63M[{"date":"2020-12-31","value":61.9,"profit":true},{"date":"2021-12-31","value":75.66,"profit":true},{"date":"2022-12-31","value":88.05,"profit":true},{"date":"2023-12-31","value":92.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin58.62%60.99%60.50%60.20%59.88%[{"date":"2020-12-31","value":96.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.2,"profit":true},{"date":"2023-12-31","value":98.71,"profit":true},{"date":"2024-12-31","value":98.19,"profit":true}]
Operating Expenses167.19M160.91M170.55M254.09M232.36M[{"date":"2020-12-31","value":65.8,"profit":true},{"date":"2021-12-31","value":63.33,"profit":true},{"date":"2022-12-31","value":67.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.45,"profit":true}]
Operating Income(24.89M)13.58M32.52M(40.77M)(1.73M)[{"date":"2020-12-31","value":-76.52,"profit":false},{"date":"2021-12-31","value":41.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-125.38,"profit":false},{"date":"2024-12-31","value":-5.32,"profit":false}]
Total Non-Operating Income/Expense(51.06M)(33.79M)(31.54M)(36.86M)(36.97M)[{"date":"2020-12-31","value":-5105700000,"profit":false},{"date":"2021-12-31","value":-3379100000,"profit":false},{"date":"2022-12-31","value":-3153900000,"profit":false},{"date":"2023-12-31","value":-3686000000,"profit":false},{"date":"2024-12-31","value":-3697300000,"profit":false}]
Pre-Tax Income(50.18M)(3.38M)18.75M(55.14M)(17.18M)[{"date":"2020-12-31","value":-267.56,"profit":false},{"date":"2021-12-31","value":-18,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-294.02,"profit":false},{"date":"2024-12-31","value":-91.62,"profit":false}]
Income Taxes(784.00K)9.89M4.02M214.00K(5.13M)[{"date":"2020-12-31","value":-7.93,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40.68,"profit":true},{"date":"2023-12-31","value":2.16,"profit":true},{"date":"2024-12-31","value":-51.9,"profit":false}]
Income After Taxes(49.40M)(13.27M)14.73M(55.36M)(12.05M)[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-375.79,"profit":false},{"date":"2024-12-31","value":-81.81,"profit":false}]
Income From Continuous Operations(49.40M)(13.27M)14.73M(33.73M)(12.05M)[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-228.95,"profit":false},{"date":"2024-12-31","value":-81.81,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(49.40M)(13.27M)14.73M(55.36M)(12.05M)[{"date":"2020-12-31","value":-335.33,"profit":false},{"date":"2021-12-31","value":-90.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-375.79,"profit":false},{"date":"2024-12-31","value":-81.81,"profit":false}]
EPS (Diluted)0.070.170.460.440.45[{"date":"2020-12-31","value":16.22,"profit":true},{"date":"2021-12-31","value":36.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.65,"profit":true},{"date":"2024-12-31","value":97.83,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CERT
Cash Ratio 1.66
Current Ratio 2.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CERT
ROA (LTM) 1.12%
ROE (LTM) -0.25%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CERT
Debt Ratio Lower is generally better. Negative is bad. 0.31
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.69

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CERT
Trailing PE NM
Forward PE 24.94
P/S (TTM) 4.69
P/B 1.71
Price/FCF 110
EV/R 5.01
EV/Ebitda 23.63

FAQs

What is Certara Inc share price today?

Certara Inc (CERT) share price today is $11.4

Can Indians buy Certara Inc shares?

Yes, Indians can buy shares of Certara Inc (CERT) on Vested. To buy Certara Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CERT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Certara Inc be purchased?

Yes, you can purchase fractional shares of Certara Inc (CERT) via the Vested app. You can start investing in Certara Inc (CERT) with a minimum investment of $1.

How to invest in Certara Inc shares from India?

You can invest in shares of Certara Inc (CERT) via Vested in three simple steps:

  • Click on Sign Up or Invest in CERT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Certara Inc shares
What is Certara Inc 52-week high and low stock price?

The 52-week high price of Certara Inc (CERT) is $17.75. The 52-week low price of Certara Inc (CERT) is $8.63.

What is Certara Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Certara Inc (CERT) is 1.71

What is the Market Cap of Certara Inc?

The market capitalization of Certara Inc (CERT) is $1.86B

What is Certara Inc’s stock symbol?

The stock symbol (or ticker) of Certara Inc is CERT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top